Emlodin

Medicinal product

(Invented) name

Emlodin

Active substance (s)

Amlodipinas

Strength

2,5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C08CA01, Amlodipine

Marketing authorisation holder

Egis Pharmaceuticals PLC, Vengrija

Date of authorisation

2001-10-08

Date of renewal

2010-02-04

Documents

1852_1-3_Emlodin_tab_RPP_200424.docx

1852_1-3_Pakuotes lapelis_200424.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Amlodipinas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
3166	8669	1008669	lizdinė plokštelė	N30		Receptinis	LT/1/01/1852/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-06-15	Išregistruotas
2010-02-04	Perregistruotas
2001-10-08	Registruotas